CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Eli Lilly & Co - LLY CFD

    597.69
    1.72%
    0.45
    Low: 585.36
    High: 597.69
    Market Trading Hours* (UTC) Opens on Monday at 14:30

    Mon - Fri: 14:30 - 21:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.45
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026207 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026207%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003985 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003985%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Eli Lilly and Co ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 587.58
    Open* 589.74
    1-Year Change* 58.51%
    Day's Range* 585.36 - 597.69
    52 wk Range 309.20-629.97
    Average Volume (10 days) 4.19M
    Average Volume (3 months) 68.06M
    Market Cap 562.56B
    P/E Ratio 107.21
    Shares Outstanding 949.31M
    Revenue 32.07B
    EPS 5.53
    Dividend (Yield %) 0.76274
    Beta 0.33
    Next Earnings Date Feb 6, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 8, 2023 597.69 9.74 1.66% 587.95 598.17 584.43
    Dec 7, 2023 587.58 1.63 0.28% 585.95 588.70 577.45
    Dec 6, 2023 589.20 -0.85 -0.14% 590.05 593.76 584.45
    Dec 5, 2023 587.98 4.98 0.85% 583.00 591.47 579.30
    Dec 4, 2023 585.51 3.61 0.62% 581.90 586.76 573.95
    Dec 1, 2023 582.96 -8.02 -1.36% 590.98 601.59 582.96
    Nov 30, 2023 590.67 -0.28 -0.05% 590.95 595.96 586.04
    Nov 29, 2023 591.75 1.78 0.30% 589.97 594.30 584.10
    Nov 28, 2023 591.47 0.79 0.13% 590.68 595.13 589.13
    Nov 27, 2023 591.19 -10.43 -1.73% 601.62 602.95 590.43
    Nov 24, 2023 600.54 3.99 0.67% 596.55 603.09 596.55
    Nov 22, 2023 594.90 0.19 0.03% 594.71 598.91 586.46
    Nov 21, 2023 592.46 -5.09 -0.85% 597.55 601.09 591.63
    Nov 20, 2023 597.58 5.91 1.00% 591.67 604.63 589.36
    Nov 17, 2023 591.61 0.66 0.11% 590.95 595.96 586.95
    Nov 16, 2023 588.32 -0.49 -0.08% 588.81 594.84 581.57
    Nov 15, 2023 588.34 -20.51 -3.37% 608.85 612.32 584.13
    Nov 14, 2023 610.71 2.80 0.46% 607.91 616.05 602.45
    Nov 13, 2023 612.43 21.08 3.56% 591.35 618.38 577.61
    Nov 10, 2023 597.61 2.59 0.44% 595.02 598.70 585.52

    Eli Lilly & Co Events

    Time (UTC) Country Event
    Tuesday, December 12, 2023

    Time (UTC)

    14:00

    Country

    US

    Event

    Eli Lilly and Co 2024 Guidance Call
    Eli Lilly and Co 2024 Guidance Call

    Forecast

    -

    Previous

    -
    Tuesday, February 6, 2024

    Time (UTC)

    10:59

    Country

    US

    Event

    Q4 2023 Eli Lilly and Co Earnings Call
    Q4 2023 Eli Lilly and Co Earnings Call

    Forecast

    -

    Previous

    -

    Time (UTC)

    13:30

    Country

    US

    Event

    Q4 2023 Eli Lilly and Co Earnings Release
    Q4 2023 Eli Lilly and Co Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 28541.4 28318.4 24539.8 22319.5 21493.3
    Revenue 28541.4 28318.4 24539.8 22319.5 21493.3
    Cost of Revenue, Total 6629.8 7312.8 5483.3 4721.2 4681.7
    Gross Profit 21911.6 21005.6 19056.5 17598.3 16811.6
    Total Operating Expense 21414.1 22366.5 18481.8 17287.9 17958.8
    Selling/General/Admin. Expenses, Total 6440.4 6431.6 6121.2 6213.8 5975.1
    Research & Development 7190.8 7025.9 6085.7 5595 5051.2
    Unusual Expense (Income) 1153.1 1596.2 791.6 757.9 2250.8
    Operating Income 7127.3 5951.9 6058 5031.6 3534.5
    Interest Income (Expense), Net Non-Operating -679.5 -137.5 -326.6 -320.2 -83.2
    Other, Net 358.6 341.1 1498.5 554.5 228.8
    Net Income Before Taxes 6806.4 6155.5 7229.9 5265.9 3680.1
    Net Income After Taxes 6244.8 5581.7 6193.7 4637.9 3325.9
    Net Income Before Extra. Items 6244.8 5581.7 6193.7 4637.9 3325.9
    Net Income 6244.8 5581.7 6193.7 8318.4 3232
    Income Available to Common Excl. Extra. Items 6244.8 5581.7 6193.7 4637.9 3325.9
    Income Available to Common Incl. Extra. Items 6244.8 5581.7 6193.7 8318.4 3232
    Diluted Net Income 6244.8 5581.7 6193.7 8318.4 3232
    Diluted Weighted Average Shares 904.619 911.681 912.505 935.684 1033.67
    Diluted EPS Excluding Extraordinary Items 6.90324 6.12243 6.78758 4.95669 3.21757
    Dividends per Share - Common Stock Primary Issue 3.92 3.4 2.96 2.58 2.25
    Diluted Normalized EPS 8.15561 7.79951 7.63447 5.70063 5.37021
    Total Extraordinary Items 0 0 3680.5 -93.9
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 8312.1 6960 7301.8 6941.6 6488
    Revenue 8312.1 6960 7301.8 6941.6 6488
    Cost of Revenue, Total 1807.4 1626.7 1548.1 1579.1 1430.5
    Gross Profit 6504.7 5333.3 5753.7 5362.5 5057.5
    Total Operating Expense 6186.4 5466 5465.4 5265.1 5277.9
    Selling/General/Admin. Expenses, Total 1925.4 1749.2 1643.2 1614.2 1625.1
    Research & Development 2356.5 1985.1 1995.9 1802.9 1781.9
    Unusual Expense (Income) 97.1 105 278.2 268.9 440.4
    Operating Income 2125.7 1494 1836.4 1676.5 1210.1
    Interest Income (Expense), Net Non-Operating -139.2 -82.3 198.4 -184.7 -189.9
    Other, Net 102.4 118 61.6 73.7 70.7
    Net Income Before Taxes 2088.9 1529.7 2096.4 1565.5 1090.9
    Net Income After Taxes 1763.2 1344.9 1937.7 1451.7 952.5
    Net Income Before Extra. Items 1763.2 1344.9 1937.7 1451.7 952.5
    Net Income 1763.2 1344.9 1937.7 1451.7 952.5
    Income Available to Common Excl. Extra. Items 1763.2 1344.9 1937.7 1451.7 952.5
    Income Available to Common Incl. Extra. Items 1763.2 1344.9 1937.7 1451.7 952.5
    Diluted Net Income 1763.2 1344.9 1937.7 1451.7 952.5
    Diluted Weighted Average Shares 902.7 903.3 901.544 903.8 902.9
    Diluted EPS Excluding Extraordinary Items 1.95325 1.48887 2.14931 1.60622 1.05493
    Dividends per Share - Common Stock Primary Issue 1.13 1.13 0.98 0.98 0.98
    Diluted Normalized EPS 2.06082 1.60511 2.4547 1.88713 1.5427
    Total Extraordinary Items
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 18034.5 18452.4 17462.1 13709.6 20549.6
    Cash and Short Term Investments 2211.8 3908.6 3681.3 2438.5 7408.9
    Cash & Equivalents 2067 3818.5 3657.1 2337.5 7320.7
    Short Term Investments 144.8 90.1 24.2 101 88.2
    Total Receivables, Net 8558.9 8127.2 6929 5541.5 5776.8
    Accounts Receivable - Trade, Net 6896 6672.8 5875.3 4547.3 5776.8
    Total Inventory 4309.7 3886 3980.3 3190.7 3098.1
    Prepaid Expenses 2954.1 2530.6 2871.5 2538.9 2036.7
    Total Assets 49489.8 48806 46633.1 39286.1 43908.4
    Property/Plant/Equipment, Total - Net 10144 8985.1 8681.9 8405 7996.1
    Property/Plant/Equipment, Total - Gross 20377.4 18961.8 18252.6 17566.6 16663
    Accumulated Depreciation, Total -10233.4 -9976.7 -9570.7 -9161.6 -8666.9
    Goodwill, Net 4073 3892 3766.5 3679.4 1366.6
    Intangibles, Net 7206.6 7691.9 7450 6618 1068
    Long Term Investments 2901.8 3212.6 2966.8 1962.4 2005.4
    Other Long Term Assets, Total 7129.9 6572 6305.8 4911.7 10922.7
    Total Current Liabilities 17138.2 15052.7 12481.6 11775.2 11888.1
    Accounts Payable 1930.6 1670.6 1606.7 1405.3 1207.1
    Accrued Expenses 9843.9 7803.9 6850.2 5849.1 5805.1
    Notes Payable/Short Term Debt 1498 0 0 1494.2 498.9
    Current Port. of LT Debt/Capital Leases 3.1 1538.3 8.7 5.1 603.3
    Other Current Liabilities, Total 3862.6 4039.9 4016 3021.5 3773.7
    Total Liabilities 38840 39826.8 40991.5 36679.2 34079.7
    Total Long Term Debt 14737.5 15346.4 16586.6 13817.9 9196.4
    Long Term Debt 14737.5 15346.4 16586.6 13817.9 9196.4
    Capital Lease Obligations
    Minority Interest 125.6 175.6 183.6 92.2 1080.4
    Other Liabilities, Total 6751.4 7518.4 9639.8 8806.4 10602.1
    Total Equity 10649.8 8979.2 5641.6 2606.9 9828.7
    Common Stock 594.1 596.3 598.2 598.8 661
    Additional Paid-In Capital 6921.4 6833.4 6778.5 6685.3 6583.6
    Retained Earnings (Accumulated Deficit) 10042.6 8958.5 7830.2 4920.4 11395.9
    Treasury Stock - Common -3063.7 -3065.9 -3068.9 -3074 -3082.6
    Unrealized Gain (Loss) -37.1 3.7 14.8 4.9
    Other Equity, Total -3807.5 -4346.8 -6511.2 -6528.5 -5729.2
    Total Liabilities & Shareholders’ Equity 49489.8 48806 46633.1 39286.1 43908.4
    Total Common Shares Outstanding 950.182 953.653 956.59 957.526 1057.64
    Other Current Assets, Total 0 2229.1
    Deferred Income Tax 87.3 1733.7 2099.9 2187.5 1312.7
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 23007 21331.6 20811.4 18034.5 17639.9
    Cash and Short Term Investments 2493.9 2829.1 3669.3 2211.8 2742.1
    Cash & Equivalents 2380.8 2694.5 3545.9 2067 2617.4
    Short Term Investments 113.1 134.6 123.4 144.8 124.7
    Total Receivables, Net 10363.8 9171.4 9022.1 8558.9 8324.8
    Accounts Receivable - Trade, Net 8167.1 7516.1 7526.2 6896 6715.3
    Total Inventory 4901.4 4798.7 4544.8 4309.7 3831.1
    Prepaid Expenses 5247.9 4532.4 3575.2 2954.1 2741.9
    Total Assets 57915.5 54814 53163 49489.8 47461.5
    Property/Plant/Equipment, Total - Net 11863.2 11277.4 10546.2 10144 9311.3
    Property/Plant/Equipment, Total - Gross 22631 21909 21032.2 20377.4 19385.3
    Accumulated Depreciation, Total -10767.8 -10631.6 -10486 -10233.4 -10074
    Goodwill, Net 4085.2 4078.9 4073.1 4073 3891.6
    Intangibles, Net 6781.7 6903.5 7087.1 7206.6 7124.1
    Long Term Investments 2691.7 2745.1 2750.4 2901.8 2574.6
    Other Long Term Assets, Total 9486.7 8477.5 7894.8 7129.9 6920
    Total Current Liabilities 21998.2 18915 16010 17138.2 15652.8
    Accounts Payable 2435.1 2474.2 2015.9 1930.6 1683.2
    Accrued Expenses 12755.5 11257.6 10269.2 9843.9 9552.5
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 2244.7 661.6 3.1 1501.1 1744.6
    Other Current Liabilities, Total 4562.9 4521.6 3721.8 3862.6 2672.5
    Total Liabilities 46695.1 43750.2 41972.6 38840 37391.4
    Total Long Term Debt 17923.6 18158.4 18880.5 14737.5 14143.8
    Long Term Debt 17923.6 18158.4 18880.5 14737.5 14143.8
    Deferred Income Tax 87.3 171.9
    Minority Interest 87 85.5 104.5 125.6 95.8
    Other Liabilities, Total 6686.3 6591.3 6977.6 6751.4 7327.1
    Total Equity 11220.4 11063.8 11190.4 10649.8 10070.1
    Common Stock 593.6 593.6 593.5 594.1 594.1
    Additional Paid-In Capital 7160 6948.6 6793.1 6921.4 6829
    Retained Earnings (Accumulated Deficit) 10309.9 10368.5 10639.3 10042.6 10006.5
    Treasury Stock - Common -3058.2 -3058.2 -3058.2 -3063.7 -3063.7
    Unrealized Gain (Loss) -45.6 -33.5 -28.3 -37.1 -39.3
    Other Equity, Total -3739.3 -3755.2 -3749 -3807.5 -4256.5
    Total Liabilities & Shareholders’ Equity 57915.5 54814 53163 49489.8 47461.5
    Total Common Shares Outstanding 949.303 949.286 949.267 950.182 950.177
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 6244.8 5581.7 6193.7 8318.4 3232
    Cash From Operating Activities 7084.4 7260.7 6499.6 4836.6 5524.5
    Cash From Operating Activities 1522.5 1547.6 1323.9 1232.6 1609
    Deferred Taxes -2185.2 -802.3 -134.5 62.4 326.8
    Non-Cash Items 1516.8 1956.3 -136.1 -3089.6 2735.4
    Cash Taxes Paid 2672.9 1598.8 954.6 1180.5 1101.5
    Cash Interest Paid 323.7 338 345.8 305.5 223.8
    Changes in Working Capital -14.5 -1022.6 -747.4 -1687.2 -2378.7
    Cash From Investing Activities -3261.6 -2762.3 -2258.9 -8082.9 1906
    Capital Expenditures -2484 -1873.2 -2029.1 -1353.5 -3018.2
    Other Investing Cash Flow Items, Total -777.6 -889.1 -229.8 -6729.4 4924.2
    Cash From Financing Activities -5406.7 -4131.3 -3137.1 -2324.5 -5904.9
    Financing Cash Flow Items -308.9 -295.9 -241.6 -200.1 -372.8
    Total Cash Dividends Paid -3535.8 -3086.8 -2687.1 -2409.8 -2311.8
    Issuance (Retirement) of Stock, Net -1500 -1250 -500 -4400 -2491
    Issuance (Retirement) of Debt, Net -62 501.4 291.6 4685.4 -729.3
    Foreign Exchange Effects -167.6 -205.7 216 -89.9 -63.6
    Net Change in Cash -1751.5 161.4 1319.6 -5660.7 1462
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 1344.9 6244.8 4307.1 2855.4 1902.9
    Cash From Operating Activities 1730.6 7084.4 5504.7 3319.9 2499.2
    Cash From Operating Activities 362.3 1522.5 1147.5 784.6 435.7
    Deferred Taxes -559.4 -2185.2 -2195.6 -1125 -506.6
    Non-Cash Items 418.7 1516.8 1424.2 922.5 712.7
    Changes in Working Capital 164.1 -14.5 821.5 -117.6 -45.5
    Cash From Investing Activities -688.8 -3261.6 -2401.1 -1477.7 -1013.8
    Capital Expenditures -903.5 -2484 -1928.4 -1308.2 -857.2
    Other Investing Cash Flow Items, Total 214.7 -777.6 -472.7 -169.5 -156.6
    Cash From Financing Activities 412.3 -5406.7 -4265.3 -3002 -2878.3
    Financing Cash Flow Items -281 -308.9 -295.2 -290 -282.4
    Total Cash Dividends Paid -1017.2 -3535.8 -2651.4 -1769.2 -885.5
    Issuance (Retirement) of Stock, Net -750 -1500 -1500 -1500 -1500
    Issuance (Retirement) of Debt, Net 2460.5 -62 181.3 557.2 -210.4
    Foreign Exchange Effects 24.8 -167.6 -39.4 -35.8 33.6
    Net Change in Cash 1478.9 -1751.5 -1201.1 -1195.6 -1359.3
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Lilly Endowment, Inc. Investment Advisor 10.5098 99768810 -215000 2023-10-11 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 7.3277 69561163 -51527 2023-06-30 LOW
    PNC Investments LLC Investment Advisor 5.4335 51579491 -42265 2023-06-30 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 4.2533 40376432 -376075 2023-06-30 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 3.5688 33878417 642274 2023-06-30 LOW
    Fidelity Management & Research Company LLC Investment Advisor 3.3365 31673624 848150 2023-06-30 LOW
    Capital World Investors Investment Advisor 2.8303 26867581 -720959 2023-06-30 LOW
    PRIMECAP Management Company Investment Advisor 2.4804 23546201 -1821349 2023-06-30
    T. Rowe Price Associates, Inc. Investment Advisor 2.4328 23094519 1440826 2023-06-30 LOW
    State Farm Insurance Companies Insurance Company 1.8291 17363691 -47034 2023-06-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.6018 15205501 338077 2023-06-30 LOW
    Wellington Management Company, LLP Investment Advisor/Hedge Fund 1.5223 14451309 -5872958 2023-06-30 LOW
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.9837 9337978 1041252 2022-12-31 LOW
    Jennison Associates LLC Investment Advisor/Hedge Fund 0.904 8581438 7274 2023-06-30 LOW
    JP Morgan Asset Management Investment Advisor 0.85 8069220 2093954 2023-06-30 LOW
    Capital Research Global Investors Investment Advisor 0.7145 6782977 654026 2023-06-30 LOW
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.6619 6282976 -544842 2023-06-30 LOW
    Capital International Investors Investment Advisor 0.653 6198772 -339139 2023-06-30 LOW
    Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.6433 6107260 196292 2023-06-30 LOW
    BofA Global Research (US) Research Firm 0.5775 5482046 -604500 2023-06-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Eli Lilly Company profile

    Eli Lilly and Company is engaged in the drug manufacturing business. The company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products.  Explore the Eli Lilly stock at Capital.com. Monitor Lilly shares in real time. With our website you can stay updated on Lilly share price.  

    Industry: Pharmaceuticals (NEC)

    Lilly Corporate Ctr
    Drop Code 1094
    INDIANAPOLIS
    INDIANA 46285-0001
    US

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    US100

    16,080.90 Price
    +0.500% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 7.0

    BTC/USD

    43,891.00 Price
    -0.320% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Oil - Crude

    71.41 Price
    +2.320% 1D Chg, %
    Long position overnight fee -0.0204%
    Short position overnight fee -0.0015%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    XRP/USD

    0.67 Price
    -1.850% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading